Genevieve Laforet

Company: Aspa Therapeutics

Job title: Vice President, Clinical Development

Seminars:

Complement-Mediated Thrombotic Microangiopathy Associated with Systemic AAV Gene Therapy 4:00 pm

• Review of the complement system and pathophysiology of thrombotic microangiopathy (TMA) • Learnings from the TMA experience in AAV gene therapy programs to date • Mechanistic hypotheses regarding TMA risk • Practical considerations around TMA surveillance, prophylaxis and managementRead more

day: Day One